Chemoinformaics analysis of 3,4-Dimethyl-5-pentylfuran-2(5H)-one
Molecular Weight | 182.263 | nRot | 4 |
Heavy Atom Molecular Weight | 164.119 | nRig | 12 |
Exact Molecular Weight | 182.131 | nRing | 1 |
Solubility: LogS | -1.701 | nHRing | 1 |
Solubility: LogP | 0.44 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 31 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 13 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 18 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 11 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 31.9763 |
nHD | 0 | BPOL | 20.6617 |
QED | 0.574 |
Synth | 1.964 |
Natural Product Likeliness | -0.664 |
NR-PPAR-gamma | 0.005 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0.003 |
HIA | 0.007 |
CACO-2 | -4.577 |
MDCK | 0.0000326 |
BBB | 0.954 |
PPB | 0.456486 |
VDSS | 1.449 |
FU | 0.523126 |
CYP1A2-inh | 0.823 |
CYP1A2-sub | 0.927 |
CYP2c19-inh | 0.1 |
CYP2c19-sub | 0.322 |
CYP2c9-inh | 0.031 |
CYP2c9-sub | 0.631 |
CYP2d6-inh | 0.006 |
CYP2d6-sub | 0.216 |
CYP3a4-inh | 0.012 |
CYP3a4-sub | 0.203 |
CL | 4.344 |
T12 | 0.803 |
hERG | 0.014 |
Ames | 0.216 |
ROA | 0.52 |
SkinSen | 0.186 |
Carcinogencity | 0.602 |
EI | 0.799 |
Respiratory | 0.806 |
NR-Aromatase | 0.028 |
Antiviral | No |
Prediction | 0.717899 |